SI-BONE, Inc. (SIBN)
Every FINRA and SEC series the site collects for SI-BONE, Inc.: short interest with days to cover, daily short sale volume, fails to deliver and Form 4 insider trades. Listed on Nasdaq, classified by the SEC as surgical & medical instruments & apparatus.
5.6M
Short interest
settlement 2026-08-31
9.9
Days to cover
+5.4% vs prior
50.5%
Short share of volume
2026-09-17
2,969
Fails to deliver
settlement 2026-08-24
Mon 9 Nov
Next earnings
estimated; last year 2025-11-10
-$3.4M
Insider flow, 90 days
0 buys, 18 sells
As of 2026-09-17.
Short interest
FINRA, twice a month; the last 12 months shown, all 48 settlements in the JSONAs of 31 August 2026, short interest in SIBN is 5,626,900 shares, up 546,250 shares over the last month. Over the last 48 readings it ranged from 1,016,670 shares (31 January 2025) to 5,978,449 shares (30 June 2026). The latest reading sits at the top of that range. At the reported average volume of 571K shares a day that is 9.9 days to cover, elevated.
Embed this chartkeeps the attribution line it carries
<iframe src="https://xoomar.com/embed/stocks/sibn" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
| Settlement | Shares short | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|
| 2026-08-31 | 5,626,900 | +5.4% | 570,725 | 9.86 |
| 2026-08-14 | 5,336,842 | +5.0% | 488,986 | 10.91 |
| 2026-07-31 | 5,080,650 | -7.7% | 466,131 | 10.90 |
| 2026-07-15 | 5,507,086 | -7.9% | 616,520 | 8.93 |
| 2026-06-30 | 5,978,449 | +0.9% | 702,381 | 8.51 |
| 2026-06-15 | 5,924,425 | +0.8% | 432,184 | 13.71 |
| 2026-05-29 | 5,879,708 | +3.1% | 543,269 | 10.82 |
| 2026-05-15 | 5,704,493 | +25.7% | 1,126,542 | 5.06 |
| 2026-04-30 | 4,537,455 | -2.0% | 497,310 | 9.12 |
| 2026-04-15 | 4,632,479 | +19.3% | 832,483 | 5.56 |
| 2026-03-31 | 3,882,808 | +7.7% | 599,692 | 6.47 |
| 2026-03-13 | 3,603,947 | +25.5% | 538,789 | 6.69 |
| 2026-02-27 | 2,871,776 | +6.7% | 655,700 | 4.38 |
| 2026-02-13 | 2,691,361 | +10.8% | 398,497 | 6.75 |
| 2026-01-30 | 2,429,780 | -6.3% | 496,126 | 4.90 |
| 2026-01-15 | 2,594,038 | +6.8% | 708,203 | 3.66 |
| 2025-12-31 | 2,428,753 | -0.0% | 386,284 | 6.29 |
| 2025-12-15 | 2,429,007 | -8.0% | 532,036 | 4.57 |
| 2025-11-28 | 2,639,548 | -7.0% | 625,646 | 4.22 |
| 2025-11-14 | 2,839,813 | +2.7% | 802,508 | 3.54 |
| 2025-10-31 | 2,765,679 | +4.1% | 295,244 | 9.37 |
| 2025-10-15 | 2,655,786 | +10.4% | 510,795 | 5.20 |
| 2025-09-30 | 2,406,382 | +14.0% | 424,753 | 5.67 |
| 2025-09-15 | 2,110,365 | -2.4% | 357,668 | 5.90 |
Daily short volume
FINRA Reg SHO, last 60 sessions. JSONAs of 17 September 2026, the short share of SIBN volume is 50.5%, down 25.0 points over the last five sessions. Over the last 52 readings it ranged from 14.0% (8 July 2026) to 79.3% (10 August 2026). The latest reading is 12.1 points below the 30-session average of 62.6%, on 272K shares reported.
| Date | Short volume | Total volume | Short share | Exempt |
|---|---|---|---|---|
| 2026-09-17 | 137K | 272K | 50.5% | 0 |
| 2026-09-16 | 85K | 150K | 56.6% | 2,911 |
| 2026-09-15 | 84K | 150K | 55.8% | 0 |
| 2026-09-14 | 152K | 213K | 71.3% | 0 |
| 2026-09-11 | 156K | 254K | 61.3% | 0 |
| 2026-09-10 | 271K | 359K | 75.5% | 0 |
| 2026-09-09 | 61K | 184K | 33.2% | 0 |
| 2026-09-08 | 95K | 150K | 63.5% | 0 |
| 2026-09-04 | 77K | 131K | 59.1% | 0 |
| 2026-09-03 | 133K | 294K | 45.1% | 4,916 |
| 2026-09-02 | 167K | 417K | 40.1% | 17,451 |
| 2026-09-01 | 101K | 140K | 72.3% | 286 |
| 2026-08-31 | 55K | 90K | 61.0% | 0 |
| 2026-08-28 | 94K | 152K | 61.5% | 0 |
| 2026-08-27 | 191K | 331K | 57.8% | 0 |
| 2026-08-26 | 183K | 238K | 76.9% | 0 |
| 2026-08-25 | 78K | 124K | 63.2% | 0 |
| 2026-08-24 | 193K | 273K | 70.7% | 0 |
| 2026-08-21 | 406K | 626K | 64.9% | 0 |
| 2026-08-20 | 71K | 91K | 77.4% | 0 |
| 2026-08-19 | 105K | 180K | 58.6% | 0 |
| 2026-08-18 | 94K | 235K | 40.1% | 892 |
| 2026-08-17 | 80K | 109K | 73.9% | 2,501 |
| 2026-08-14 | 55K | 77K | 71.4% | 0 |
| 2026-08-13 | 58K | 80K | 72.0% | 3 |
| 2026-08-12 | 74K | 95K | 78.5% | 0 |
| 2026-08-11 | 115K | 171K | 67.0% | 0 |
| 2026-08-10 | 119K | 150K | 79.3% | 0 |
| 2026-08-07 | 48K | 95K | 50.7% | 0 |
| 2026-08-06 | 95K | 138K | 68.9% | 379 |
Fails to deliver
SEC, by settlement date. JSONAs of 24 August 2026, the fails-to-deliver balance in SIBN is 2,969 shares, up 2,955 shares over the last settlement date. Over the last 52 readings it ranged from 10 shares (12 September 2025) to 34,573 shares (2 December 2025). The latest reading sits at the bottom of that range.
| Settlement | Shares failed | Price | Value |
|---|---|---|---|
| 2026-08-24 | 2,969 | $19.96 | $59K |
| 2026-08-20 | 14 | $19.91 | $279 |
| 2026-08-18 | 2,379 | $18.69 | $44K |
| 2026-08-11 | 259 | $18.84 | $5K |
| 2026-08-07 | 1,047 | $18.14 | $19K |
| 2026-08-06 | 348 | $18.04 | $6K |
| 2026-08-05 | 8,957 | $18.44 | $165K |
| 2026-07-28 | 10 | $17.05 | $171 |
| 2026-07-21 | 597 | $17.12 | $10K |
| 2026-07-16 | 2,465 | $17.25 | $43K |
| 2026-07-06 | 592 | $17.11 | $10K |
| 2026-07-02 | 2,064 | $16.80 | $35K |
| 2026-07-01 | 635 | $16.32 | $10K |
| 2026-06-30 | 24,417 | $16.88 | $412K |
| 2026-06-29 | 16,841 | $17.33 | $292K |
| 2026-06-26 | 15 | $16.76 | $251 |
| 2026-06-24 | 15,189 | $15.95 | $242K |
| 2026-06-22 | 2,234 | $15.84 | $35K |
| 2026-06-15 | 641 | $15.42 | $10K |
| 2026-06-02 | 920 | $13.87 | $13K |
| 2026-05-29 | 2,724 | $14.41 | $39K |
| 2026-05-04 | 3,965 | $13.21 | $52K |
| 2026-04-07 | 100 | $13.21 | $1K |
| 2026-03-12 | 415 | $14.05 | $6K |
| 2026-02-27 | 5,591 | $16.23 | $91K |
| 2026-02-09 | 5,962 | $15.59 | $93K |
| 2025-12-02 | 34,573 | $18.87 | $652K |
| 2025-11-13 | 12 | $18.00 | $216 |
| 2025-11-12 | 390 | $18.22 | $7K |
| 2025-11-07 | 584 | $15.19 | $9K |
Insider trades
SEC Form 4, newest first, 50 of 100 shown. JSONInsiders at SIBN reported 18 open-market sells worth $3.4M in the last 90 days and no open-market buys. Sells alone are a weak signal; insiders sell for tax, diversification and estate reasons all the time. Latest filing: DUNN JEFFREY W on 2026-09-01.
| Date | Insider | Title | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| 2026-09-01 | DUNN JEFFREY W | n/a | Sell | 1K | $18.91 | $26K | 16K |
| 2026-09-01 | DUNN JEFFREY W | n/a | Sell | 19K | $18.91 | $352K | 17K |
| 2026-09-01 | DUNN JEFFREY W | n/a | Option exercise | 1K | $4.68 | $6K | 36K |
| 2026-09-01 | DUNN JEFFREY W | n/a | Option exercise | 19K | $4.68 | $87K | 35K |
| 2026-08-24 | Maheshwari Anshul | Chief Op & Financial Officer | Sell | 12K | $20.11 | $234K | 223K |
| 2026-08-24 | FRANCIS LAURA | Chief Executive Officer | Sell | 26K | $20.12 | $523K | 291K |
| 2026-08-21 | Maheshwari Anshul | Chief Op & Financial Officer | Sell | 11K | $20.02 | $225K | 235K |
| 2026-08-21 | FRANCIS LAURA | Chief Executive Officer | Sell | 4K | $20.02 | $79K | 317K |
| 2026-08-20 | FRANCIS LAURA | Chief Executive Officer | Sell | 52K | $19.46 | $1.0M | 321K |
| 2026-08-19 | Maheshwari Anshul | Chief Op & Financial Officer | Sell | 6K | $19.55 | $112K | 246K |
| 2026-08-17 | Maheshwari Anshul | Chief Financial Officer | Sell | 2K | $18.62 | $41K | 252K |
| 2026-08-17 | Maheshwari Anshul | Chief Financial Officer | Sell | 2K | $18.68 | $46K | 254K |
| 2026-08-17 | FRANCIS LAURA | Chief Executive Officer | Sell | 2K | $18.63 | $37K | 494K |
| 2026-08-17 | FRANCIS LAURA | Chief Executive Officer | Sell | 2K | $18.68 | $42K | 490K |
| 2026-08-17 | FRANCIS LAURA | Chief Executive Officer | Sell | 3K | $18.66 | $60K | 493K |
| 2026-08-17 | FRANCIS LAURA | Chief Executive Officer | Sell | 4K | $18.66 | $68K | 496K |
| 2026-08-17 | FRANCIS LAURA | Chief Executive Officer | Sell | 4K | $18.66 | $73K | 500K |
| 2026-08-17 | PISETSKY MICHAEL A. | SVP, Ops & Adm/Chief Legal Ofr | Sell | 2K | $18.65 | $35K | 274K |
| 2026-08-17 | PISETSKY MICHAEL A. | SVP, Ops & Adm/Chief Legal Ofr | Sell | 2K | $18.62 | $35K | 276K |
| 2026-08-03 | DUNN JEFFREY W | n/a | Sell | 20K | $18.46 | $369K | 16K |
| 2026-08-03 | DUNN JEFFREY W | n/a | Option exercise | 20K | $4.68 | $94K | 36K |
| 2026-06-05 | DUNN JEFFREY W | n/a | Sell | 4K | $15.25 | $55K | 16K |
| 2026-06-04 | West Thomas A. | n/a | Grant | 11K | $0.00 | $0 | 38K |
| 2026-06-04 | Nishimura Mika | n/a | Grant | 11K | $0.00 | $0 | 44K |
| 2026-06-04 | Freund John Gordon | n/a | Grant | 11K | $0.00 | $0 | 54K |
| 2026-06-04 | Davis Timothy E JR | n/a | Grant | 11K | $0.00 | $0 | 77K |
| 2026-06-04 | DUNN JEFFREY W | n/a | Grant | 11K | $0.00 | $0 | 20K |
| 2026-06-04 | HILLEMAN JERYL L | n/a | Grant | 11K | $0.00 | $0 | 44K |
| 2026-05-29 | Davis Timothy E JR | n/a | Sell | 4K | $14.14 | $49K | 66K |
| 2026-05-28 | Davis Timothy E JR | n/a | Sell | 4K | $14.47 | $55K | 69K |
| 2026-05-28 | Davis Timothy E JR | n/a | Option exercise | 12K | $4.32 | $52K | 73K |
| 2026-05-18 | PISETSKY MICHAEL A. | SVP, Ops & Adm/Chief Legal Ofr | Sell | 2K | $14.64 | $27K | 281K |
| 2026-05-18 | PISETSKY MICHAEL A. | SVP, Ops & Adm/Chief Legal Ofr | Sell | 2K | $14.63 | $27K | 281K |
| 2026-05-18 | Maheshwari Anshul | Chief Financial Officer | Sell | 2K | $14.65 | $32K | 260K |
| 2026-05-18 | Maheshwari Anshul | Chief Financial Officer | Sell | 2K | $14.71 | $36K | 261K |
| 2026-05-18 | FRANCIS LAURA | Chief Executive Officer | Sell | 3K | $14.73 | $47K | 503K |
| 2026-05-18 | FRANCIS LAURA | Chief Executive Officer | Sell | 4K | $14.75 | $54K | 533K |
| 2026-05-18 | FRANCIS LAURA | Chief Executive Officer | Sell | 2K | $14.57 | $29K | 536K |
| 2026-05-18 | FRANCIS LAURA | Chief Executive Officer | Sell | 2K | $14.67 | $33K | 538K |
| 2026-05-18 | FRANCIS LAURA | Chief Executive Officer | Sell | 4K | $14.75 | $57K | 540K |
| 2026-05-04 | DUNN JEFFREY W | n/a | Sell | 337 | $13.15 | $4K | 9K |
| 2026-04-07 | Hinckley Greg K | n/a | Option exercise | 3K | $5.94 | $18K | 105K |
| 2026-04-02 | PISETSKY MICHAEL A. | SVP, Ops & Adm/Chief Legal Ofr | Sell | 34 | $12.61 | $429 | 283K |
| 2026-04-02 | PISETSKY MICHAEL A. | SVP, Ops & Adm/Chief Legal Ofr | Sell | 1K | $12.86 | $17K | 283K |
| 2026-04-02 | Maheshwari Anshul | Chief Financial Officer | Sell | 2K | $12.81 | $20K | 263K |
| 2026-04-02 | Maheshwari Anshul | Chief Financial Officer | Sell | 2K | $12.92 | $23K | 265K |
| 2026-04-01 | PISETSKY MICHAEL A. | SVP, Ops & Adm/Chief Legal Ofr | Sell | 2K | $12.95 | $23K | 284K |
| 2026-03-12 | Nishimura Mika | n/a | Sell | 4K | $13.83 | $57K | 33K |
| 2026-02-17 | RECUPERO ANTHONY J | n/a | Sell | 3K | $15.45 | $47K | 243K |
| 2026-02-17 | RECUPERO ANTHONY J | n/a | Sell | 11K | $15.41 | $172K | 246K |
Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are the rarer, stronger signal.
Planned sales (Form 144)
Newest first. JSON19 Form 144 notices on file for SIBN worth $7.9M at the prices reported; 7 in the last 90 days worth $3.6M. Latest: ANSHUL MAHESHWARI filed on 2026-08-24 to sell 11,636 shares ($232K) from 2026-08-24.
| Filed | Seller | Shares | Market value | Of outstanding | Sale from | Broker |
|---|---|---|---|---|---|---|
| 2026-08-24 | ANSHUL MAHESHWARIOfficer | 12K | $232K | 0.026% | 2026-08-24 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-08-24 | DAVID & LAURA FRANCIS JOINT REV TRU/A DTD 01/03/2003Director, Officer | 26K | $518K | 0.058% | 2026-08-24 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-08-21 | ANSHUL MAHESHWARIOfficer | 11K | $219K | 0.025% | 2026-08-21 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-08-21 | DAVID & LAURA FRANCIS JOINT REV TRU/A DTD 01/03/2003Director, Officer | 4K | $76K | 0.009% | 2026-08-21 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-08-20 | DAVID & LAURA FRANCIS JOINT REV TRU/A DTD 01/03/2003Director, Officer | 52K | $1.0M | 0.116% | 2026-08-20 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-08-19 | ANSHUL MAHESHWARIOfficer | 6K | $110K | 0.013% | 2026-08-19 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-08-03 | THE JEFFREY W DUNN LIVING TRUST DTD 05/17/2012Director | 80K | $1.4M | 0.180% | 2026-08-03 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-05-29 | TIMOTHY E DAVIS JRDirector | 4K | $49K | 0.008% | 2026-05-29 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-03-12 | MIKA NISHIMURADirector | 4K | $57K | 0.009% | 2026-03-12 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-01-08 | The Jeffrey W. Dunn Living TrustDirector | 60K | $1.3M | 0.138% | 2026-01-08 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-01-02 | ANSHUL MAHESHWARIOfficer | 2K | $31K | 0.004% | 2026-01-02 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-12-08 | The Jeffrey W. Dunn Living TrustDirector | 20K | $394K | 0.046% | 2025-12-08 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-11-21 | MICHAEL PISETSKY SEPARATE PROPERTY TRUSTOfficer | 20K | $374K | 0.046% | 2025-11-21 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-11-21 | ANSHUL MAHESHWARIOfficer | 20K | $371K | 0.046% | 2025-11-21 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-11-18 | DAVID & LAURA FRANCIS JOINT REV TR U/A DTD 01/03/2003Director, Officer | 5K | $97K | 0.012% | 2025-11-18 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-11-12 | DANIEL WOLFDirector | 14K | $260K | 0.033% | 2025-11-12 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-11-12 | ANSHUL MAHESHWARIOfficer | 3K | $41K | 0.006% | 2025-11-11 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-11-12 | DAVID & LAURA FRANCIS JOINT REV TR U/A DTD 01/03/2003Director, Officer | 5K | $85K | 0.012% | 2025-11-11 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-11-12 | The Jeffrey W. Dunn Living TrustDirector | 80K | $1.3M | 0.184% | 2025-11-11 | Morgan Stanley Smith Barney LLC Executive Financial Services |
Large holders (13D and 13G)
One row per reporting person, newest filing first. JSON19 holders above 5% have filed on SIBN, all on Schedule 13G (passive). The largest reported stake is Mathew P. Arens at 18.4% of the class (8,120,986 shares), filed 2026-05-07 for an event on 2026-04-30.
| Filed | Form | Holder | Shares | Of class | Event |
|---|---|---|---|---|---|
| 2026-08-14 | 13G | Cadian Capital Management, LPinvestment adviser, partnership | 3.3M | 7.5% | 2026-06-30 |
| 2026-08-14 | 13G | Cadian Capital Management GP, LLCother entity, parent holding company | 3.3M | 7.5% | 2026-06-30 |
| 2026-08-14 | 13G | ERIC BANNASCHindividual, parent holding company | 3.3M | 7.5% | 2026-06-30 |
| 2026-07-30 | 13G/Ano. 7 | BlackRock, Inc.parent holding company | 3.6M | 8.0% | 2026-06-30 |
| 2026-05-07 | 13G/Ano. 1 | Mathew P. Arensindividual | 8.1M | 18.4% | 2026-04-30 |
| 2026-05-07 | 13G/Ano. 1 | First Light Asset Management, LLCinvestment adviser | 8.0M | 18.0% | 2026-04-30 |
| 2026-04-24 | 13G/Ano. 6 | BlackRock, Inc.parent holding company | 3.1M | 6.9% | 2026-03-31 |
| 2026-03-27 | 13G/Ano. 1 | The Vanguard Groupinvestment adviser | 0 | 0.0% | 2026-03-13 |
| 2026-02-17 | 13G/Ano. 6 | OrbiMed Advisors LLCinvestment adviser | 0 | 0.0% | 2025-12-31 |
| 2026-02-17 | 13G/Ano. 6 | OrbiMed Capital LLCinvestment adviser | 0 | 0.0% | 2025-12-31 |
| 2026-02-13 | 13G/Ano. 5 | BROWN ADVISORY INCparent holding company | 2.5M | 5.8% | 2025-12-31 |
| 2026-02-13 | 13G/Ano. 5 | BROWN ADVISORY LLCinvestment adviser | 2.5M | 5.8% | 2025-12-31 |
| 2026-02-13 | 13G/Ano. 3 | Stowers Institute for Medical Researchparent holding company | 2.3M | 5.3% | 2025-12-31 |
| 2026-02-13 | 13G/Ano. 3 | American Century Companies, Inc.parent holding company | 2.3M | 5.3% | 2025-12-31 |
| 2026-02-13 | 13G/Ano. 3 | American Century Investment Management, Inc.investment adviser | 2.3M | 5.3% | 2025-12-31 |
| 2026-02-13 | 13G/Ano. 3 | American Century Mutual Funds, Inc.investment company | 1.8M | 4.1% | 2025-12-31 |
| 2026-02-13 | 13G/Ano. 5 | BROWN INVESTMENT ADVISORY & TRUST CObank | 10K | 0.0% | 2025-12-31 |
| 2026-02-13 | 13G/Ano. 5 | SIGNATURE FINANCIAL MANAGEMENT, INC.investment adviser | 1K | 0.0% | 2025-12-31 |
| 2026-02-13 | 13G/Ano. 5 | BROWN ADVISORY LTDinvestment adviser | 342 | 0.0% | 2025-12-31 |
| 2026-02-12 | 13G | Champlain Investment Partners, LLCinvestment adviser | 2.1M | 4.9% | 2025-09-30 |
| 2025-12-05 | 13G | Mathew P. Arensindividual | 5.2M | 11.9% | 2025-11-30 |
| 2025-12-05 | 13G | First Light Asset Management, LLCinvestment adviser | 5.0M | 11.6% | 2025-11-30 |
| 2025-11-14 | 13G/Ano. 2 | American Century Investment Management, Inc.investment adviser | 2.8M | 6.6% | 2025-09-30 |
| 2025-11-14 | 13G/Ano. 2 | American Century Companies, Inc.parent holding company | 2.8M | 6.6% | 2025-09-30 |
| 2025-11-14 | 13G/Ano. 2 | Stowers Institute for Medical Researchparent holding company | 2.8M | 6.6% | 2025-09-30 |
| 2025-11-14 | 13G/Ano. 2 | American Century Mutual Funds, Inc.investment company | 2.3M | 5.3% | 2025-09-30 |
13F holders
Tracked managers holding SIBN at their latest 13F. JSON6 of the 30 tracked managers held SIBN at their latest 13F, $27.3M in total at quarter-end prices. Point72 Asset Management is the largest at $12.9M (0.0% of its portfolio) as of 2026-06-30. Over the prior quarter 1 added shares and 5 cut.
| Fund | Quarter | Shares | Value | Of portfolio | Change in shares |
|---|---|---|---|---|---|
| Point72 Asset Management | 2026-06-30 | 790K | $12.9M | 0.01% | -50K |
| Millennium Management | 2026-06-30 | 364K | $5.9M | 0.00% | -5K |
| AQR Capital Management | 2026-06-30 | 254K | $4.1M | 0.00% | +196K |
| D. E. Shaw & Co. | 2026-06-30 | 186K | $3.0M | 0.00% | -3K |
| Renaissance Technologies | 2026-06-30 | 44K | $720K | 0.00% | -429K |
| Citadel Advisors | 2026-06-30 | 35K | $563K | 0.00% | -193K |
Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.
Financials
SEC XBRL, as filed. JSONIn Q2 2026 (quarter ended 2026-06-30) SI-BONE, Inc. reported revenue of $56.0M, up 15.2% from the same quarter a year earlier, and net loss of $4.1M (-0.09 diluted EPS). In FY 2025 it generated -$675K of operating cash flow. As of 2026-06-30, cash was $33.1M against $35.6M of debt.
- Cash
- $33.1M
- Debt
- $35.6M
- Equity
- $182.3M
- Total assets
- $248.8M
- Shares outstanding
- 44,818,575
Quarterly, last 8 quarters
| Quarter | Period end | Revenue | Net income | Margin | Diluted EPS |
|---|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $56.0M | -$4.1M | -7.3% | -0.09 |
| Q1 2026 | 2026-03-31 | $52.6M | -$4.3M | -8.2% | -0.10 |
| Q4 2025derived | 2025-12-31 | $56.3M | n/a | n/a | n/a |
| Q3 2025 | 2025-09-30 | $48.7M | -$4.6M | -9.4% | -0.11 |
| Q2 2025 | 2025-06-30 | $48.6M | -$6.2M | -12.7% | -0.14 |
| Q1 2025 | 2025-03-31 | $47.3M | -$6.5M | -13.8% | -0.15 |
| Q4 2024derived | 2024-12-31 | $49.0M | n/a | n/a | n/a |
| Q3 2024 | 2024-09-30 | $40.3M | -$6.6M | -16.3% | -0.16 |
Fiscal years, with buybacks and dividends
| Fiscal year | Ends | Revenue | Net income | Operating cash flow | Capex | Buybacks | Dividends |
|---|---|---|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $200.9M | n/a | -$675K | $8.4M | n/a | n/a |
| FY 2024 | 2024-12-31 | $167.2M | n/a | -$12.4M | $10.5M | n/a | n/a |
| FY 2023 | 2023-12-31 | $138.9M | n/a | -$18.7M | $7.8M | n/a | n/a |
| FY 2022 | 2022-12-31 | $106.4M | n/a | -$41.7M | $9.5M | n/a | n/a |
| FY 2021 | 2021-12-31 | $90.2M | n/a | -$39.5M | $6.4M | n/a | n/a |
Quarters are the three-month figures the company reports; a fourth quarter marked derived is the fiscal year less the three reported quarters, since companies report it only inside the 10-K. Fiscal years are the annual figures. Buybacks are cash paid to repurchase common stock in the year (XBRL PaymentsForRepurchaseOfCommonStock), not authorizations. Balance sheet lines are as of 2026-06-30; shares outstanding as of 2026-07-29 from the cover page.
What this page is
SI-BONE, Inc. in the regulatory record
Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page pulls every series the site collects for one ticker onto one URL, keyed by the SEC's own ticker list, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.
Each section has its own history table, a summary sentence built from the rows (last value, change, range with dates) and its own JSON and CSV links. Nothing on the page is written by a model; the sentences change only when the data does. A page exists only for companies with data in at least two series, and every section says when its source last updated.
This page follows SI-BONE, Inc. (SIBN), SEC CIK 1459839, listed on Nasdaq, classified by the SEC as surgical & medical instruments & apparatus. The cross-market tables live on the short interest and insider transactions hubs.
Source and method
- Short interest
- FINRA consolidated short interestTwice a month, about eight business days after settlement. Latest 2026-08-31.JSON and CSV
- Daily short volume
- FINRA Reg SHO daily filesEvery trading day, loaded the following morning. Latest 2026-09-17.JSON and CSV
- Fails to deliver
- SEC fails-to-deliver dataTwice a month, a few weeks after the half month ends. Latest 2026-08-24.JSON and CSV
- Planned sales
- SEC EDGAR Form 144EDGAR read every 30 minutes; a notice is filed on or before the sell order. Latest 2026-08-24.JSON and CSV
- Large holders
- SEC EDGAR Schedule 13D and 13GEDGAR read every 30 minutes; 13D within five business days of crossing 5%, 13G on the passive schedule. Latest 2026-08-14.JSON and CSV
- 13F holders
- SEC EDGAR Form 13F-HRQuarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
- Financials
- SEC XBRL company factsRefreshed weekly from the SEC's structured data; values are as filed in the 10-Q and 10-K. Latest 2026-06-30.JSON and CSV
- Earnings dates
- SEC EDGAR 8-K Item 2.02 (full-text search)EDGAR full-text search read twice a day; the estimate is last year's date plus 52 weeks. Latest 2026-08-03.JSON and CSV
- Insider trades
- SEC EDGAR Form 4EDGAR read every 30 minutes; filings are due two business days after the trade. Latest 2026-09-01.JSON and CSV
- Company record
- EDGAR filing index for CIK 1459839Ticker, name and exchange from the SEC's company list, refreshed weekly.
- Rate limits
- 30 requests a minute without a key, 120 a minute with a key from a free account.
Data checks. Every dataset is checked against its source once a day. This dataset passed the last run, 18 Sep 05:40 UTC.
How to read it
- Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
- Insider buys next to a crowded short are the combination that has historically preceded squeezes; insider sells next to a crowded short are common and mean little.
- Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.
Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.
Other companies the SEC classifies as surgical & medical instruments & apparatus
- BSXBOSTON SCIENTIFIC CORP
- TNDMTANDEM DIABETES CARE INC
- DXCMDEXCOM INC
- PENPenumbra Inc
- MMM3M CO
- LMATLEMAITRE VASCULAR INC
- INSPInspire Medical Systems, Inc.
- NVCRNovoCure Ltd
- RMDRESMED INC
- SYKSTRYKER CORP
- GKOSGLAUKOS Corp
- IRTCiRhythm Holdings, Inc.
- ICUIICU MEDICAL INC/DE
- ATECAlphatec Holdings, Inc.
- AORTARTIVION, INC.
- PODDINSULET CORP
- BDXBECTON DICKINSON & CO
- IRMDIRADIMED CORP
- ATRCAtriCure, Inc.
- UFPTUFP TECHNOLOGIES INC
- LUNGPulmonx Corp
- MMSIMERIT MEDICAL SYSTEMS INC
- ANGOANGIODYNAMICS INC
- OFIXOrthofix Medical Inc.
Datasets
Frequently Asked Questions
How much of SIBN is sold short?
What is SIBN's daily short volume?
Does SIBN have fails to deliver?
Are SIBN insiders buying or selling?
Have SIBN insiders filed to sell?
Who owns more than 5% of SIBN?
What did SIBN report last quarter?
Which funds hold SIBN?
Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.